Risk and Vulnerable, Medicalized Bodies by Koerber, Amy et al.
Poroi 
An Interdisciplinary Journal of Rhetorical Analysis 
and Invention 
ISSN 2151-2957 
Volume 11 
Issue 1 A Forum on the Rhetoric of Food 
DOI: 10.13008/2151-2957.1222 
pps. 1-9 
5-2015 
Risk and Vulnerable, Medicalized Bodies 
Amy Koerber 
Texas Tech University, amy.koerber@ttu.edu 
Lora Arduser 
University of Cincinnati, lora.arduser@uc.edu 
Jeannie Bennett 
Texas Tech University, jeannie.bennett@ttu.edu 
Lauren Kolodziejski 
California Polytechnic State University – San Luis Obispo, lkolodzi@calpoly.edu 
Shaunak Sastry 
University of Cincinnati, shaunak.sastry@uc.edu 
See next page for additional authors 
Copyright © 2015 Amy Koerber, Lora Arduser, Jeannie Bennett, Lauren Kolodziejski, Shaunak 
Sastry, and L. Paul Strait 
This work is licensed under a Creative Commons Attribution 3.0 License. 
Recommended Citation 
Koerber, Amy; Arduser, Lora; Bennett, Jeannie; Kolodziejski, Lauren; Sastry, Shaunak; and Strait, L. Paul. 
"Risk and Vulnerable, Medicalized Bodies." Poroi 11, Iss. 1 (2015): p. 1-9 https://doi.org/10.13008/
2151-2957.1222 
Hosted by Iowa Research Online 
This Article is brought to you for free and open access by Iowa Research Online. It has been accepted for inclusion 
in Poroi by an authorized administrator of Iowa Research Online. For more information, please contact lib-
ir@uiowa.edu. 
Risk and Vulnerable, Medicalized Bodies 
Authors 
Amy Koerber, Lora Arduser, Jeannie Bennett, Lauren Kolodziejski, Shaunak Sastry, and L. Paul Strait 
This article is available in Poroi: https://ir.uiowa.edu/poroi/vol11/iss1/13 
  
Risk and Vulnerable, 
Medicalized Bodies
ARST Pre-Conference at NCA, 2014
Amy Koerber 
Texas Tech University
Lubbock, TX 
Lora Arduser 
University of Cincinnati
Cincinnati, OH
Jeannie Bennett
Texas Tech University
Lubbock, TX 
Lauren Kolodziejski
California Polytechnic State University 
San Luis Obispo, CA
Shaunak Sastry
University of Cincinnati
Cincinnati, OH
L. Paul Strait 
University of Southern California
Los Angeles, CA
 
Poroi 11,1 (May 2015)
In Ulrich Beck's risk society, modernization has generated a 
collection of humanly 
result of scientific and industrial development. They are not limited 
in time or space and they cross
boundaries. We often perceive ourselves as having little ability to 
calculate, and therefore, compensate for such risks (Lash 
Wynne, 1992).  This panel addressed how some of the most 
vulnerable bodies
diagnosed with mental illness
for risk intervention and sometimes as inherently risky.
In her presentation, 
elements articulate risk in the childhood vaccine controversy. 
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generated risks. These risks are largely the 
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Lauren Kolodziejski discussed how visual 
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Through an examination of common images incorporated in 
commentary around vaccine hesitancy, Kolodziejski noted how 
visual cues embedded within these images encourage viewing 
vaccines as risky among parents already feeling uncertain. A 
photograph of a child receiving a shot frequently accompanies 
articles about the vaccine issue, serving as a visual illustration of 
the issue to be discussed in the text that follows. A typical 
articulation of this image pictures the moment of injection, 
displaying a close-up shot of the needle being inserted into an arm, 
often cropped so closely that no faces are shown. For Kolodziejski, 
worth noting is how frequently in these images a faceless doctor or 
nurse administers the vaccine to the child, who looks on with 
apprehension or cries in pain. While such depictions emphasize the 
medical nature of inoculation, they also decontextualize the 
practice, abstracting it completely from a personalized practitioner-
patient interaction.  
Rhetorically, such images can undermine rather than encourage 
vaccine uptake. Studies have shown a correlation between lack of 
trust in the medical system or personal health care provider and 
lower vaccine coverage (Senier, 2008; Smith et al., 2011, 140). For 
parents who feel like vaccine policies are applied as one-size-fits-all, 
these images can reinforce impressions that health care workers are 
detached from or do not care about the individual receiving the 
vaccine. Since parents trying to make vaccine decisions may be 
exposed to media coverage more than to their own doctors — 
particularly if they are prone to turning to the Internet for 
information — these images can subtly influence an uncertain 
parent’s attitude.  
Kolodziejski brought the widely disseminated image of 
vaccination to bear on the practice of displaying images of autistic 
children as “proof” for claims that vaccines cause autism. For 
example, at a “Green Our Vaccines” rally held in Washington, D.C. 
in 2008, parents marched holding up images of their own children. 
Rhetorically, these images operate as synecdoches for these 
parents’ narratives and contrast with official depersonalized ones. 
They personalize the issue and visualize the claimed risk in a highly 
relatable way. The amassing of images serves as amplification, 
making the issue seem more widespread, thereby potentially 
creating a false consensus effect (Kahan, Slovic, Braman, and 
Gastil, 2010, 205), whereby parents might overestimate the 
numbers of other parents who are hesitant about or completely 
adverse to vaccines.  
Kolodziejski concludes that visuals can enter conversations 
about risk in any number of ways, from supplements within media 
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coverage to means for displaying technical information in a more 
understandable way. Rhetoricians have much to contribute in 
examining how these visuals articulate risks and how visuals might 
tap into the emotional component of risk perception and 
assessment. 
Jeannie Bennett and Amy Koerber addressed the topic of 
“Articulating Risk” through a study of shifting risk perceptions in 
medical recommendations for treating bipolar disorder during 
pregnancy.  Throughout most of its history, bipolar disorder has 
been seen as a condition that should not necessarily be treated with 
pharmaceuticals during pregnancy.  In the last ten years, however, 
medical beliefs have dramatically shifted.  Pregnancy, once thought 
to confer a protective effect against bipolar disorder (Grof et al. 
2000), is now seen as a period of high risk for it (Viguera et al. 
2002; Viguera et al. 2007).  Whereas medication was once deemed 
too risky, the risks that an unmedicated woman poses to herself, 
her fetus, and those around her now seem to demand 
pharmaceutical intervention.  
Bennett and Koerber begin by noting that the inherent riskiness 
of the bipolar pregnant woman, as depicted in today’s medical 
literature, is grounded in fears of the hormonal fluctuation that is 
known to occur during pregnancy. In the current medical literature, 
women are reduced to their menstrual cycles, which are quantified 
to such a fine degree that women are, essentially, always in their 
menstrual cycles (see Burt and Ragson, 2004). For example, 
women with bipolar disorder are conceptualized as constantly in 
flux and moody; they are “doubly moody.” Researchers and 
clinicians assume that a woman’s hormones must in some way 
exacerbate bipolar disorder, making a woman more moody, more 
pathological and more uncontrollable than men with bipolar 
disorder (see Leibenluft, 1996, for example). Her body-mood is 
constructed as inherently pathological and dangerous for the fetus--
more so than pharmaceutical intervention, which the physician can 
presumably monitor and control to a greater extent than is the case 
for a woman’s own hormones. 
The assumption that a woman’s hormones must have some 
effect on bipolar disorder has, however, never been tested, but 
instead is taken as a given. Many researchers and clinicians frame 
their investigations of women and bipolar disorder with the 
assumption that hormones must, in some way, affect bipolar 
disorder, although the research has not yet demonstrated this link. 
Because researchers’ efforts to find such a link are continually 
frustrated, Bennett and Koerber argued, the unproven assumption 
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that a woman’s hormones are a “special case” in bipolar disorder 
has become linked to an appeal for newer, better science.  
Bennett and Koerber’s claims about the rhetorical function of 
hormones in today’s medical discourse on bipolar pregnant women 
were strengthened with reference to a brief history of “hormone” as 
a scientific term. The term was first used in a 1905 lecture by 
British physician Ernest Henry Starling.  This lecture inserted itself 
into a contentious debate about what controls the human body: Is it 
only the brain and nervous system, or is something else involved? 
In reading Starling’s account of this debate, we see traces of some 
common binaries in Western thought, including oppositions 
between logic and emotion and mind and body. We also see 
evidence that medical scientists were afraid of these newly 
discovered “chemical messengers,” and that their fears were based 
in their desire to control the human body. As Starling says, 
“Absolute control over the workings of the human body is the goal 
of medical science.” 
This rhetorical history provides a useful frame for 
understanding some aspects of current medical discourse on the 
bipolar pregnant woman. The shift in medical recommendations is 
linked to medical beliefs about women's hormones, which are 
constructed as inherently risky, in a manner that reflects the same 
fears about control, and loss of control, that were expressed in 
Starling’s 1905 lectures.  As they continue this research, Bennett 
and Koerber hope to learn more about the reasons why these old 
fears have resurfaced in today’s medical discourse. 
Shaunak Sastry and Lora Arduser examined how current 
medical discourse on gestational diabetes mellitus, like much of the 
current medical discourse on pregnancy more generally, attempts 
to minimize risks.  Most women in the United States come to know 
the risks of gestational diabetes through the discourses and 
practices of the modern prenatal system, a system that assumed its 
current form after World War II (Seigel, 2014). From that time 
forward, there was a national trend to centralize prenatal care in 
clinic or hospitals. This system is based on the assumption that the 
work of pregnancy is a healthy baby and that pregnant bodies are 
“sites through which social, political and environmental risks are 
managed” (Seigel, 2014, 13). Like the larger risk society Beck 
discusses, risks in this system do not necessarily increase, but risk 
does organize the system (Beck, 1992.) 
Sastry and Arduser investigate how gestational diabetes is 
constructed as a risk, but also how women, as embodied agents, 
accept, negotiate, and challenge these risks. Their research derives 
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from critical approaches to health communication in exploring how 
patients organize meanings around gestational diabetes and the 
power dynamics that inhere in the construction of such meanings 
(Dutta, 2010; Lupton, 1994, 2013; Zoller and Dutta, 2008).  They 
analyzed the rhetorical construction of gestational diabetes risk 
within publicly available textual material and the construction of 
gestational diabetes risks by pregnant women. In an age where 
health and risk information is increasingly present online, pregnant 
women have access to significant amounts of information that 
communicate the risks, diagnoses, and management of gestational 
diabetes. Although in most cases, gestational diabetes is 
circumscribed to the duration of pregnancy, it is also associated 
with significant risks to both mother and child after pregnancy. 
Given these risks, and the significant comorbidities between 
gestational and Type 2 diabetes (itself a public health concern), an 
increasing number of women are exposed to messages and risk 
discourses around gestational diabetes.  As of this writing, however, 
there has not yet been a systematic study of gestational diabetes 
from a health communication perspective.  
Through their analysis Sastry and Arduser argue that the 
production of gestational diabetes risk discourse has theoretical 
and practical implications not merely as a mode of Foucaultian 
biopolitics, but also as a site of patient (and female) agency (Rose, 
2007).  At the preconference, they reported on the beginnings of 
their data collection, which included the discourse analysis of 
interview data (n=5) and a generative rhetorical criticism of 
biomedical texts on GDM (Kline, 2007). They discussed four 
themes that have emerged in their research: 1) desire for the 
“perfect birth,” 2) surveillance 3) the notion of being a “responsible” 
mother, and 4) maternal vs. fetal risks. 
In his contribution to the panel, L. Paul Strait examined the 
debate surrounding the proposal to include the diagnosis of 
psychosis risk syndrome (PRS) in the American Psychiatric 
Association's most recent diagnostic manual, DSM-5. Defining a 
state of affairs as a disease or illness (that is, its 'medicalization') 
has become an important rhetorical topic in contemporary medical 
discourse. Once formulated as a health concern and pathologized, a 
problem falls under the technical gaze of expertise as a putative 
disease entity, whenever acceptable subjective and objective criteria 
can be developed and institutionalized.  Medicalization comes in 
two forms: “the pathologizing of normal biological or social 
variation and ... the portrayal of the presence of risk factors for 
disease as a disease state itself” (Heath, 2006, e146). The latter 
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category, the medicalization of risk, has produced a new form of 
life—the asymptomatically or pre-symptomatically ill.  
Although the proposed diagnostic category has been very 
controversial, psychiatry has long flirted with developing early 
interventions for those adolescents and young adults who are at 
risk for schizophrenia and other psychotic disorders, and over 100 
clinics have been set up over the last decade to study PRS and its 
'treatment' ( manovi, 2011). As a syndrome, PRS is characterized by 
a constellation of signs and symptoms whose clustering together 
suggests a medically relevant morbid unity, an underlying disease 
process that can be called by name, assigned a prognosis, and, in an 
ideal world, made to respond to a specific indicated treatment. In 
this case, however, the syndrome signifies in reality only a risk of 
developing a future disease process. In this case, however, the 
syndrome signifies only the risk of developing a future disease 
process, and the potential interventions—cognitive therapy, 
essential fatty acid supplementation, and the prophylactic 
administration of anti-psychotic medication—carry substantial 
risks of their own. 
Because these risk factors are non-specific, approximately two-
thirds of those identified will not experience an acute psychotic 
episode within a two-year period absent any intervention (McGorry 
et al., 2009). Such a high false-positive rate magnifies the potential 
social, psychological, and biological hazards of intervention 
(Frances, 2010).  Yet, in this controversy concepts like 'false-
positives' are contested in a polyphonic field of divergent 
perspectives concerning the etiology and pathogenesis of psychotic 
disorders.  This field is characterized by an avoidance of an 
“interpretive-definitional” stasis point in the interests of consensus-
building (Prelli, 1989, 146). Does the syndrome signify a risk state 
or the presence of attenuated psychotic symptoms?  Does a 
diagnosis imply susceptibility, predisposition, prodrome, or 
probability?  Is psychosis endopathogenic or exopathogenic?  What 
does being 'at risk' entail beyond a prediction about one's future 
mental health?  Unanswered (and unasked), these lingering 
questions distort evaluations of relative risk.  Instead, interlocutors 
take up questions about the risks of legitimation:  the unknown 
effects of pharmaceutical marketing to non-specialists. There also 
seems to be confusion about whether the points of dispute in the 
controversy are technical or practical in nature. These aspects of the 
controversy, Strait argues, reflect the rhetorical dynamics of risk 
society under conditions of reflexive modernity. The result is 
protracted dissensus, as of yet unresolved.  
 Koerber et al. 7 Poroi 11,1 (May 2015) 
SUMMARY 
Although presenters explored four disparate topics, follow-up 
discussion and audience questions suggested some common 
threads that tied the presentations to each other and to the pre-
conference theme of “Articulating Risk.” One important theme is 
the manner in which articulations of risk can change so 
dramatically from one era to the next. In different ways, each of the 
risk-related topics addressed by the four presenters on the panel 
can be usefully illuminated through Judy Segal’s notion of 
kairology; that is, an individual or condition that is perceived as 
risky at one time and place in history might have been perceived as 
entirely safe at another time and place.  Another important theme 
was the question of agency.  On this theme, some important 
differences emerged among the four presentations.  For the topics 
addressed in the Bennett-Koerber and the Sastry-Arduser 
presentations, discussions of agency emerged from questions about 
the maternal-fetal dyad and actions that pregnant mothers are 
expected to take to protect the fetus.  For the topic of Kolodziejski’s 
presentation, discussions of agency assume the adult parent to be a 
decision maker about vaccines, even though the child is the one 
who is the object of the perceived risks that are in question.  For the 
topic addressed by Strait, the DSM apparatus is a means by which 
experts can steer the broader institutional practices of psychiatry, 
but concerns over their agency as experts ultimately proved to be 
the dispositive risk in the controversy. Despite these differences, an 
important point of consensus among the panelists was the need to 
resist simple definitions of risky situations that too readily assign 
responsibility for managing risk to the most vulnerable individuals 
in our society, but at the same time to make sure we articulate risks 
in ways that protect those in society who are the most vulnerable. 
Achieving this delicate balance will require different kinds of 
decision-making and rhetorical agency in different kinds of risk 
articulations, as exemplified in the four diverse topics addressed in 
this presentation. 
 
  
 Koerber et al. 8 Poroi 11,1 (May 2015) 
 
REFERENCE LIST 
Beck, U. Risk Society: Towards a New Modernity. New Delhi: 
Sage, 1992. 
Burt, V.K. and N. Ragson, “Special Considerations in Treating 
Bipolar Disorder in Women.” Bipolar Disorders 6 (2004): 2-
13. 
Dutta, M. J. “The Critical Cultural Turn in Health Communication: 
Reflexivity, Solidarity, and Praxis.” Health Communication 
25 (2010): 534-539.  
Frances, A. J. “DSM5 'Psychosis Risk Syndrome'--Far Too Risky.” 
Psychology Today (2010): 
http://www.psychologytoday.com/blog/dsm5-in-
distress/201003/dsm5-psychosis-risk-syndrome-far-too-risky, 
accessed 2/7/12. 
Grof, P., W. Robbins, A. Matin, A. Berghoefer,  M. Vojtechovsky, A. 
Nilsson, and C. Robertson.  “Protective Effect of Pregnancy in 
Women with Lithium-Responsive Bipolar Disorder.” Journal 
of Affective Disorders 61 (2000): 31-39. 
Kline, K. N. “Cultural Sensitivity and Health Promotion: Assessing 
Breast Cancer Education Pamphlets Designed for African 
American Women.” Health Communication 21 (2007): 85-96. 
Heath, I. “Combating Disease Mongering: Daunting But 
Nonetheless Essential.” PLoS Med 3(2006): e146. 
doi:10.1371/journal.pmed.0030146 
Kahan, D., P. Slovic, D. Braman, and J. Gastil. “Fear of Democracy: 
A Cultural Evaluation of Sunstein on Risk: A Review of Laws 
of Fear: Beyond the Precautionary Principle (2005) by Cass 
R. Sunstein.” In P. Slovic (Ed.) The Feeling of Risk: New 
Perspectives on Risk Perception. (Pp. 183–213). London: 
Earthscan, 2010. 
Kecmanovi, D. Controversies and Dilemmas in Contemporary 
Psychiatry. New Brunswick, NJ: Transaction Publishers, 
2011. 
Leibenluft, E. “Women with Bipolar Illness: Clinical and Research 
Issues.” American Journal of Psychiatry 153 (1996): 163-173. 
 Koerber et al. 9 Poroi 11,1 (May 2015) 
Lupton, D. “Toward the Development of Critical Health 
Communication Praxis.” Health Communication 6 (1994): 
55-67.  
------ Risk. London: Routledge, 2013. 
McGorry, P. D., B. Nelson, G.P. Amminger, A. Bechdolf, S.M. 
Francey,  G. Berger, et al. “Intervention in Individuals at 
Ultra-High Risk for Psychosis: A Review and Future 
Directions.” Journal of Clinical Psychiatry 70(2009): 1206–
1213.  
Prelli, L. J. A Rhetoric of Science: Inventing Scientific Discourse. 
Columbia, SC: University of South Carolina Press, 1989. 
Rose, N. The Politics of Life Itself: Biomedicine, Power, and 
Subjectivity in the Twenty-first Century. Princeton, NJ: 
Princeton University Press, 2007. 
Seigel, M. The Rhetoric of Pregnancy. Chicago: the University of 
Chicago Press, 2014. 
Senier, L. “‘It’s Your Most Precious Thing:’ Worst-case Thinking, 
Trust, and Parental Decision Making about Vaccinations.” 
Sociological Inquiry 78 (2008): 207–229.  
Smith, P. J., S.G. Humiston, E.K. Marcuse, Z. Zhao, C.G. Dorell, C. 
Howes, and B. Hibbs. “Parental Delay or Refusal of Vaccine 
Doses, Childhood Vaccination Coverage at 24 Months of Age, 
and the Health Belief Model.” Public Health Reports 126 
Suppl 2 (2011): 135–146. 
Starling, E.H. “The Croonian Lectures.” Lancet 26 (1905): 579-583. 
Viguera, A.C., L.S. Cohen, R.J. Baldessarini, R. Nonacs. “Managing 
Bipolar Disorder During Pregnancy: Weighing the Risks and 
Benefits.” Canadian Journal of Psychiatry 47 (2002): 426-
436. 
Viguera, A.C., T. Whitfield, R.J. Baldessarini, D.J. Newport, Z. 
Stowe, A. Reminick, A. Zurick, L.S. Cohen. “Risk of 
Recurrence in Women with Bipolar Disorder during 
Pregnancy: Prospective Study of Mood Stabilizer 
Discontinuation.” American Journal of Psychiatry 164 
(2007): 1817-1824. 
Zoller, H. M., and M.J. Dutta. Emerging Perspectives in Health 
Communication: Meaning, Culture, and Power. New York: 
Routledge/Taylor and Francis Group, 2008. 
 
